Supply of pre-screened patients for clinical trials. Delivered via easy-to-use and safe software directly to the sites selected and preferred by sponsor.
A Biotec company approched Medicollect about a phase 3 study which ws much delayed caused by difficulty in finding patients for a MS study. That target was 120 patients and only 20 was randomised. Medicollect set up a campaign via Medicollect MS Research Panel and established a steady delivery flow of pre-screened potential patients for the sites. The Biotec company saved time and costs of setting up new investigator sites and could schedule the closing of the study.